The purpose of this contract is to carry out the development and manufacture of pharmaceutical preparations to be used in the medications development program for addiction treatment at the national…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95021D00024
- Awardee
-
Murty Pharmaceuticals, Inc. UEI DNJBTJ3XBQM6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 7 $1,013,625 obligated
Award facts
- Opportunity
-
- Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder Pre-Solicitation · 75N95020R00036 · Posted Jun 26, 2020
- Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder Pre-Solicitation · Posted Feb 12, 2021
- Combined order value
- $1,013,625 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 14% used
- $7,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $7 million indefinite delivery contract to Murty Pharmaceuticals, Inc., a small disadvantaged minority-owned business, for the development and manufacture of pharmaceutical products to support NIDA's substance abuse and addiction treatment research programs.
Under this contract, Murty Pharmaceuticals performs a range of services including formulation development, clinical trial materials production, analytical testing, and stability studies for drug products such as morphine sulfate pellets and methamphetamine hydrochloride. Recent task orders issued to Murty have a total value of over $700,000 and cover activities like stability testing, pellet manufacturing, and cGMP production of controlled substances. This work is carried out at Murty's facility in Lexington, Kentucky in compliance with FDA regulations. The contract has an ultimate completion date of September 2026.
Description
The purpose of this contract is to carry out the development and manufacture of pharmaceutical preparations to be used in the medications development program for addiction treatment at the national institute on drug abuse (nida).
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95021D00024?
75N95021D00024 was awarded to Murty Pharmaceuticals, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2021.
How much is contract 75N95021D00024 worth?
Orders under 75N95021D00024 have obligated $1,013,625. 75N95021D00024's own ceiling is $7,000,000.
How many orders have been placed under contract 75N95021D00024?
7 orders have been placed under 75N95021D00024, the latest on September 13, 2024.
Who can order from contract 75N95021D00024?
75N95021D00024 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95021D00024 competed?
The extent of competition for 75N95021D00024 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV